new glp-1 drugs What to Make of the Coverage and Cost Landscape Diabetes advocacy group discourages use
Description
Just a simpler approach to weight loss
284: 1076410773 [DOI] [PMC free article] [PubMed] [Google Scholar] 83.Ehses JA, Casilla VR, Doty T, et al
doi: 10.1210/en.2011-1464
All these properties make GLP-1 a potent anti-diabetic agent
No, GLP-1 receptor agonists should not replace statins as first-line therapy for hypercholesterolaemia
Results We identified 3 studies of elective surgery and 4 of EGD using large databases to identify an increased risk of aspiration/pneumonia associated with GLP-1RA use
